The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

BACKGROUND: Neuroendocrine markers, which could indicate for aggressive variants of prostate cancer and Ki67 (a well-known marker in oncology for defining tumor proliferation), have already been associated with clinical outcome in prostate cancer. The aim of this study was to investigate the prognos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiol Oncol
Main Authors: Pascale, Mariarosa, Aversa, Cinzia, Barbazza, Renzo, Marongiu, Barbara, Siracusano, Salvatore, Stoffel, Flavio, Sulfaro, Sando, Roggero, Enrico, Bonin, Serena, Stanta, Giorgio
Formato: Artigo
Idioma:Inglês
Publicado em: De Gruyter 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030813/
https://ncbi.nlm.nih.gov/pubmed/27679548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2016-0033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados